Metraipolis › archive › dc_bd28380f8a38

In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML — Europe PMC PMID:41264489

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41264489
DOI
10.1093/oncolo/oyaf340
License (as archived)
solo-consultazione
Archived
2026-11-08T21:37:07.195Z
SHA-256 of the archived text
461a4993a8b54e90bf9adf9493eb96ee67c17b0c0271b1ea1ba78ef485c901d3
Stable URL of this page
https://metraipolis.com/documento/dc_bd28380f8a38

How to cite

In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML — Europe PMC PMID:41264489 — Europe PMC (en), https://europepmc.org/article/MED/41264489 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd28380f8a38 (Metraipolis archive dc_bd28380f8a38, sha256 461a4993a8b54e90bf9adf9493eb96ee67c17b0c0271b1ea1ba78ef485c901d3)
BibTeX
@misc{dcbd28380f8a38,
  title = {In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML — Europe PMC PMID:41264489},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41264489},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd28380f8a38; sha256 461a4993a8b54e90bf9adf9493eb96ee67c17b0c0271b1ea1ba78ef485c901d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41264489. Agents can read the archived copy with the MCP tool read_document.